Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17873178 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Vinorelbine and Ifosfamide as Third-line Treatment for Refractory Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Intervention: Drug: NI group

Indicates status has not been verified in more than two years